{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:02:47Z","timestamp":1778648567622,"version":"3.51.4"},"reference-count":53,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Novartis Animal Health"},{"name":"Jane Lewis Seaks Endowment"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:p>Pilot studies in our laboratory revealed that furosemide\u2010induced renin\u2010angiotensin\u2010aldosterone system (<jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>) activation was not attenuated by the subsequent co\u2010administration of benazepril. This study was designed to evaluate the effect of benazepril on angiotensin\u2010converting enzyme (<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>) activity and furosemide\u2010induced circulating<jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>activation. Our hypothesis was that benazepril suppression of<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>activity would not suppress furosemide\u2010induced circulating<jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>activation, indicated by urinary aldosterone concentration. Ten healthy hound dogs were used in this study. The effect of furosemide (2\u00a0mg\/kg p.o., q12h; Group F;<jats:italic>n<\/jats:italic>\u00a0=\u00a05) and furosemide plus benazepril (1\u00a0mg\/kg p.o., q24h; Group<jats:styled-content style=\"fixed-case\">FB<\/jats:styled-content>;<jats:italic>n<\/jats:italic>\u00a0=\u00a05) on circulating<jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>was determined by plasma<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>activity, 4\u20136\u00a0h posttreatment, and urinary aldosterone to creatinine ratio (<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C) on days \u22121, \u22122, 1, 3, and 7. There was a significant increase in the average<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C (\u03bcg\/g) after the administration of furosemide (Group F baseline [average of days \u22121 and \u22122]<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C\u00a0=\u00a00.41,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.15; day 1<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C\u00a0=\u00a01.1,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.56; day 3<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C\u00a0=\u00a00.85,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.50; day 7<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C\u00a0=\u00a01.1,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.80,<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). Benazepril suppressed<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>activity (U\/L) in Group<jats:styled-content style=\"fixed-case\">FB<\/jats:styled-content>(Group<jats:styled-content style=\"fixed-case\">FB<\/jats:styled-content>baseline<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>\u00a0=\u00a016.4,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>4.2; day 1<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>\u00a0=\u00a03.5,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>1.4; day 3<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>\u00a0=\u00a01.6,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>1.3; day 7<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>\u00a0=\u00a01.4,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>1.4,<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05) but did not significantly reduce aldosterone excretion (Group<jats:styled-content style=\"fixed-case\">FB<\/jats:styled-content>baseline<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C\u00a0=\u00a00.35,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.16; day 1<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C\u00a0=\u00a00.79,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.39; day 3<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C 0.92,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.48, day 7<jats:styled-content style=\"fixed-case\">UA<\/jats:styled-content>ldo:C\u00a0=\u00a00.99,<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>0.48,<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05). Benazepril decreased plasma<jats:styled-content style=\"fixed-case\">ACE<\/jats:styled-content>activity but did not prevent furosemide\u2010induced<jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>activation, indicating aldosterone breakthrough (escape). This is particularly noteworthy in that breakthrough is observed at the time of initiation of<jats:styled-content style=\"fixed-case\">RAAS<\/jats:styled-content>suppression, as opposed to developing after months of therapy.<\/jats:p>","DOI":"10.1111\/jvp.12154","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T06:07:54Z","timestamp":1410847674000},"page":"65-73","source":"Crossref","is-referenced-by-count":27,"title":["Aldosterone breakthrough with benazepril in furosemide\u2010activated renin\u2010angiotensin\u2010aldosterone system in normal dogs"],"prefix":"10.1111","volume":"38","author":[{"given":"A. C.","family":"Lantis","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences College of Veterinary Medicine North Carolina State University Raleigh NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Ames","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences College of Veterinary Medicine North Carolina State University Raleigh NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Atkins","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences College of Veterinary Medicine North Carolina State University Raleigh NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. C.","family":"DeFrancesco","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences College of Veterinary Medicine North Carolina State University Raleigh NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. W.","family":"Keene","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences College of Veterinary Medicine North Carolina State University Raleigh NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. R.","family":"Werre","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences College of Veterinary Medicine North Carolina State University Raleigh NC USA"},{"name":"Virginia Maryland Regional College of Veterinary Medicine Blacksburg VA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1760-2734(06)70053-4"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2007.00894.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2009.0392.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2009.0467.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.634626"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0575"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2012.07.003"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb03901.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_O.107"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00455.2004"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc0502.102962"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.52.5.530"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.1992.tb01045.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-002-0020-x"},{"key":"e_1_2_6_16_1","first-page":"1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure","volume":"11","author":"Ettinger S.J.","year":"1999","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/28.12.1863"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvc.2006.11.001"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long term treatment with enalapril or hydralazine on the renin\u2010angiotensin\u2010aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"H\u00e4ggstr\u00f6m J.","year":"1996","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1998.tb02101.x"},{"key":"e_1_2_6_21_1","first-page":"672","article-title":"Relationships between serum and urinary aldosterone, ventricular remodeling and outcome in dogs with mitral valve disease","volume":"24","author":"Hezzell M.J.","year":"2010","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.68.10.1058"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2009.06.008"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.8.844"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.59.513"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000173"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(99)00046-X"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2001.62.1793"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2006.tb00707.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.82.1.57"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.16.3.261"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.70.455"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2009.0346.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.53.3.298"},{"key":"e_1_2_6_35_1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1152\/jappl.1972.33.2.170","article-title":"Respiratory effects of hypochloremic alkalosis and potassium depletion in the dog","volume":"33","author":"Penman R.W.","year":"1972","journal-title":"Journal of Applied Physiology"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.141.10.3871"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-006-0060-5"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2009.0367.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2003"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0910457"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039104.56479.42"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.82.5.1730"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01714-4"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.234.8.1031"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1760-2734(06)70025-X"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1995.tb01075.x"},{"key":"e_1_2_6_49_1","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","article-title":"Identification of a highly specific chymase as the major angiotensin II\u2010forming enzyme in the human heart","volume":"265","author":"Urata H.","year":"1990","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.25.2.145"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.3.270"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra000050"},{"key":"e_1_2_6_53_1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2460\/ajvr.1987.48.12.1713","article-title":"Evaluation of plasma aldosterone concentrations before and after ACTH administration in clinically normal dogs and in dogs with various diseases","volume":"48","author":"Willard M.D.","year":"1987","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.69.12.1574"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvp.12154","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvp.12154","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvp.12154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T17:02:31Z","timestamp":1746378151000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvp.12154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/jvp.12154"],"URL":"https:\/\/doi.org\/10.1111\/jvp.12154","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}